Evaluation of 111In-labeled cyclic RGD peptides: tetrameric not tetravalent
about
Radiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple IntegrinsRadiolabeled cyclic RGD peptides as radiotracers for tumor imagingProgrammable multivalent display of receptor ligands using peptide nucleic acid nanoscaffolds.Impact of multiple negative charges on blood clearance and biodistribution characteristics of 99mTc-labeled dimeric cyclic RGD peptidesFITC-conjugated cyclic RGD peptides as fluorescent probes for staining integrin αvβ3/αvβ5 in tumor tissues.Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECTEvaluation of In-Labeled Cyclic RGD Peptides: Effects of Peptide and Linker Multiplicity on Their Tumor Uptake, Excretion Kinetics and Metabolic Stability.Advantages of gadolinium based ultrasmall nanoparticles vs molecular gadolinium chelates for radiotherapy guided by MRI for glioma treatment.Evaluation of K(HYNIC)(2) as a bifunctional chelator for (99m)Tc-labeling of small biomolecules.Monitoring tumor response to linifanib therapy with SPECT/CT using the integrin αvβ3-targeted radiotracer 99mTc-3P-RGD2.Anti-tumor effect of integrin targeted (177)Lu-3PRGD2 and combined therapy with Endostar.(99m)Tc-Galacto-RGD2: a novel 99mTc-labeled cyclic RGD peptide dimer useful for tumor imaging.Radiometallated peptides for molecular imaging and targeted therapy.The ubiquitous DOTA and its derivatives: the impact of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid on biomedical imaging.Matching chelators to radiometals for radiopharmaceuticals.Octadentate picolinic acid-based bispidine ligand for radiometal ions.Comparison of biological properties of 99mTc-labeled cyclic RGD Peptide trimer and dimer useful as SPECT radiotracers for tumor imaging.Molecular imaging probes derived from natural peptides.Up-regulating blood brain barrier permeability of nanoparticles via multivalent effect.
P2860
Q26801806-26E4A7FA-35ED-40CD-A607-5C1E75CF6B52Q28072021-D254A858-71DA-42F6-84C1-F6CD333762EDQ34123096-728AAF40-880D-4AEE-8879-879470129921Q34196969-73693B6B-6C90-4A03-83A6-3E72C48F42B0Q34556242-BB82FBF6-DD5D-4A85-A0FB-984E9C6FA7B7Q34912643-435B5FEB-8528-4601-B41D-77B995EED211Q35167459-38113053-3F4A-44CE-A158-9086C797148CQ36245012-33712D6B-B892-4FDF-8FD0-BB5E4A10766DQ36886786-DC2D8BA5-ECA1-4229-92DD-513621AC3E88Q37027027-AC23A900-F3B0-4577-AF8C-9E6C789571DAQ37558860-F877B2B3-7E6B-4017-9F40-24EEA90C8617Q37624526-3D63E242-F71F-4E57-AC19-E8A451CC5F8FQ37847064-59B6C3A5-A6EE-4EA7-AA29-69371F029E4CQ38080002-E3142D76-BB11-450A-972C-22F74812963FQ38156660-B1B853F7-7222-4DD7-8CD3-CD78BB802B67Q38620836-E616CA27-31D7-461D-AF6E-243D0D16B917Q38738606-B155F453-C74F-4FEA-9B84-9774857F3113Q38748846-B729B694-D93A-489A-955E-406BD4505303Q39180981-CA241C9F-6FAF-4C3E-B71D-A38A4262B756
P2860
Evaluation of 111In-labeled cyclic RGD peptides: tetrameric not tetravalent
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Evaluation of 111In-labeled cyclic RGD peptides: tetrameric not tetravalent
@ast
Evaluation of 111In-labeled cyclic RGD peptides: tetrameric not tetravalent
@en
type
label
Evaluation of 111In-labeled cyclic RGD peptides: tetrameric not tetravalent
@ast
Evaluation of 111In-labeled cyclic RGD peptides: tetrameric not tetravalent
@en
prefLabel
Evaluation of 111In-labeled cyclic RGD peptides: tetrameric not tetravalent
@ast
Evaluation of 111In-labeled cyclic RGD peptides: tetrameric not tetravalent
@en
P2093
P2860
P356
P1476
Evaluation of 111In-labeled cyclic RGD peptides: tetrameric not tetravalent
@en
P2093
Sudipta Chakraborty
P2860
P304
P356
10.1021/BC900555Q
P577
2010-05-01T00:00:00Z